Cell Viability Assays Market Research Report Information, By Product (Consumables, and Instruments), By Cell Type (Human cells, Microbial cells, and Animal cells), By Application (Stem cell research), And, By Region (North America, Europe, Asia-Pacific, And Rest of the World) –Market Forecast till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Cell Viability Assays Market, by Product

6.1 Introduction

6.2 Consumables

6.2.1 Reagents

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.2.2 Assay Kits

6.2.2.1 Tetrazolium Reduction Assay Kits

6.2.2.1.1 MIT Assay Kits

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.2.2.1.2 Other Tetrazolium Assay Kits

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.2.2.2 Resazurin Cell Viability Assay Kits

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.2.2.3 Calcein-Am Cell Viability Assay Kits

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.2.2.4 Other Assay Kits

6.2.3 Microplates

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3 Instruments

6.3.1 Automated Cell Counters

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3.2 Flow Cytometers

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3.3 Spectrophotometers

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3.4 Cell Imaging and Analysis Systems

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

Chapter 7. Global Cell Viability Assays Market, by Cell Type

7.1 Introduction

7.2 Human Cells

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.3 Microbial Cells

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.4 Animal Cells

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

Chapter 8. Global Cell Viability Assays Market, by Application

8.1 Introduction

8.2 Stem Cell Research

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.3 Clinical and Diagnostic Applications

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.4 Drug Discovery and Development

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.5 Others

Chapter 9. Global Cell Viability Assays Market, by End-User

9.1 Pharmaceutical and Biotechnology Companies

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

9.2 Academic and Research Institutes

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

9.3 Hospital and Diagnostic Centers

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

9.4 Others

Chapter 10. Global Cell Viability Assays Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Thermo Fisher Scientific

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Merck KGaA

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Bio-Rad Laboratories

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 GE Healthcare

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Danaher Corporation

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Becton, Dickinson and Company

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Promega Corporation

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Biotium

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Abcam plc

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Creative Bioarray

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Biotek Instruments

12.11.1 Overview

12.11.2 Product Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 PerkinElmer

12.12.1 Overview

12.12.2 Product Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Cell Viability Assays Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Cell Viability Assays Market Synopsis, 2023-2032

Table 2 Global Cell Viability Assays Market Estimates and Forecast, 2023-2032 (USD Million)

Table 3 Global Cell Viability Assays Market, by Region, 2023-2032 (USD Million)

Table 4 Global Cell Viability Assays Market, by Product, 2023-2032 (USD Million)

Table 5 Global Cell Viability Assays Market, by Cell Type, 2023-2032(USD Million)

Table 6 Global Cell Viability Assays Market, by Application, 2023-2032 (USD Million)

Table 7 Global Cell Viability Assays Market, by End-User, 2023-2032 (USD Million)

Table 8 North America: Cell Viability Assays Market, by Product, 2023-2032 (USD Million)

Table 9 North America: Cell Viability Assays Market, by Cell Type, 2023-2032 (USD Million)

Table 10 North America: Cell Viability Assays Market, by Application, 2023-2032 (USD Million)

Table 11 North America: Cell Viability Assays Market, by End-User, 2023-2032 (USD Million)

Table 12 US: Cell Viability Assays Market, by Product, 2023-2032 (USD Million)

Table 13 US: Cell Viability Assays Market, by Cell Type, 2023-2032 (USD Million)

Table 14 US: Cell Viability Assays Market, by Application, 2023-2032 (USD Million)

Table 15 US: Cell Viability Assays Market, by End-User, 2023-2032 (USD Million)

Table 16 Canada: Cell Viability Assays Market, by Product, 2023-2032 (USD Million)

Table 17 Canada: Cell Viability Assays Market, by Cell Type, 2023-2032 (USD Million)

Table 18 Canada: Cell Viability Assays Market, by Application, 2023-2032 (USD Million)

Table 19 Canada: Cell Viability Assays Market, by End-User, 2023-2032 (USD Million)

Table 20 South America: Cell Viability Assays Market, by Product, 2023-2032 (USD Million)

Table 21 South America: Cell Viability Assays Market, by Cell Type, 2023-2032 (USD Million)

Table 22 South America: Cell Viability Assays Market, by Application, 2023-2032 (USD Million)

Table 23 South America: Cell Viability Assays Market, by End-User, 2023-2032 (USD Million)

Table 24 Europe: Cell Viability Assays Market, by Product, 2023-2032 (USD Million)

Table 25 Europe: Cell Viability Assays Market, by Cell Type, 2023-2032 (USD Million)

Table 26 Europe: Cell Viability Assays Market, by Application, 2023-2032 (USD Million)

Table 27 Europe: Cell Viability Assays Market, by End-User, 2023-2032 (USD Million)

Table 28 Western Europe: Cell Viability Assays Market, by Product, 2023-2032 (USD Million)

Table 29 Western Europe: Cell Viability Assays Market, by Cell Type, 2023-2032 (USD Million)

Table 30 Western Europe: Cell Viability Assays Market, by Application, 2023-2032 (USD

Million)

Table 31 Western Europe: Cell Viability Assays Market, by End-User, 2023-2032 (USD

Million)

Table 32 Eastern Europe: Cell Viability Assays Market, by Product, 2023-2032 (USD Million)

Table 33 Eastern Europe: Cell Viability Assays Market, by Cell Type, 2023-2032 (USD Million)

Table 34 Eastern Europe: Cell Viability Assays Market, by Application, 2023-2032 (USD Million)

Table 35 Eastern Europe: Cell Viability Assays Market, by End-User, 2023-2032 (USD Million)

Table 36 Asia-Pacific: Cell Viability Assays Market, by Product, 2023-2032 (USD Million)

Table 37 Asia-Pacific: Cell Viability Assays Market, by Cell Type, 2023-2032 (USD Million)

Table 38 Asia-Pacific: Cell Viability Assays Market, by Application, 2023-2032 (USD Million)

Table 39 Asia-Pacific: Cell Viability Assays Market, by End-User, 2023-2032 (USD Million)

Table 40 Middle East & Africa: Cell Viability Assays Market, by Product, 2023-2032 (USD Million)

Table 41 Middle East & Africa: Cell Viability Assays Market, by Cell Type, 2023-2032 (USD Million)

Table 42 Middle East & Africa: Cell Viability Assays Market, by Application, 2023-2032 (USD

Million)

Table 43 Middle East & Africa: Cell Viability Assays Market, by End-User, 2023-2032 (USD

Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Cell Viability Assays Market

Figure 3 Segmentation Market Dynamics for Global Cell Viability Assays Market

Figure 4 Global Cell Viability Assays Market Share, by Product, 2020

Figure 5 Global Cell Viability Assays Market Share, by Cell Type, 2020

Figure 6 Global Cell Viability Assays Market Share, by Application, 2020

Figure 7 Global Cell Viability Assays Market Share, by End-User, 2020

Figure 8 Global Cell Viability Assays Market Share, by Region, 2020

Figure 9 North America: Cell Viability Assays Market Share, by Country, 2020

Figure 10 Europe: Cell Viability Assays Market Share, by Country, 2020

Figure 11 Asia-Pacific: Cell Viability Assays Market Share, by Country, 2020

Figure 12 Middle East & Africa: Cell Viability Assays Market Share, by Country, 2020

Figure 13 Global Cell Viability Assays Market: Company Share Analysis, 2020 (%)

Figure 14 Thermo Fisher Scientific: Key Financials

Figure 15 Thermo Fisher Scientific: Segmental Revenue

Figure 16 Thermo Fisher Scientific: Geographical Revenue

Figure 17 Merck KGaA: Key Financials

Figure 18 Merck KGaA: Segmental Revenue

Figure 19 Merck KGaA: Geographical Revenue

Figure 20 Bio-Rad Laboratories: Key Financials

Figure 21 Bio-Rad Laboratories: Segmental Revenue

Figure 22 Bio-Rad Laboratories: Geographical Revenue

Figure 23 G E Healthcare: Key Financials

Figure 24 G E Healthcare: Segmental Revenue

Figure 25 G E Healthcare: Geographical Revenue

Figure 26 Danaher Corporation: Key Financials

Figure 27 Danaher Corporation: Segmental Revenue

Figure 28 Danaher Corporation: Geographical Revenue

Figure 29 Becton, Dickinson and Company: Key Financials

Figure 30 Becton, Dickinson and Company: Segmental Revenue

Figure 31 Becton, Dickinson and Company: Geographical Revenue

Figure 32 Promega Corporation: Key Financials

Figure 33 Promega Corporation: Segmental Revenue

Figure 34 Promega Corporation: Geographical Revenue

Figure 35 Biotium: Key Financials

Figure 36 Biotium: Segmental Revenue

Figure 37 Biotium: Geographical Revenue

Figure 38 Abcam plc: Key Financials

Figure 39 Abcam plc: Segmental Revenue

Figure 40 Abcam plc: Geographical Revenue

Figure 41 Creative Bioarray: Key Financials

Figure 42 Creative Bioarray: Segmental Revenue

Figure 43 Creative Bioarray: Geographical Revenue

Figure 44 Biotek Instruments: Key Financials

Figure 45 Biotek Instruments: Segmental Revenue

Figure 46 Biotek Instruments: Geographical Revenue

Figure 47 PerkinElmer: Key Financials

Figure 48 PerkinElmer: Segmental Revenue

Figure 49 PerkinElmer: Geographical Revenue